BRUSSELS - Johnson & Johnson could produce 1 billion doses of its potential Covid-19 vaccine next year if it proves successful and would consider injecting healthy volunteers with the novel coronavirus if there are not enough patients for final trials, a company executive said.
Van Hoof said that production of the vaccine had already begun despite the financial risks involved, to make sure it would be available as soon as possible should it prove effective against the new coronavirus. That is why J&J is likely to conduct those trials in the United States and Latin America, the world's regions currently with the highest number of cases.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Philippines records 2,987 more Covid-19 infections, 19 deaths
Source: TODAYonline - 🏆 1. / 99 Read more »
Sinovac launches late-stage trial for potential COVID-19 vaccine in IndonesiaJAKARTA: China's Sinovac Biotech launched on Tuesday (Aug 11) a late-stage human trial involving as many as 1,620 patients in Indonesia for a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
CanSino to start Phase III trial of COVID-19 vaccine in Saudi ArabiaSaudi Arabia will soon begin Phase III clinical trials on around 5,000 people for a COVID-19 vaccine developed by China's CanSino Biologics Inc , ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Sinovac launches late-stage trial for potential Covid-19 vaccine in IndonesiaJAKARTA/BEIJING (REUTERS) - China's Sinovac Biotech launched on Tuesday(Aug 11) a late-stage human trial involving as many as 1,620 patients in Indonesia for a Covid-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
China's Sinopharm starts Phase III trial of COVID-19 vaccine in BahrainChinese state-owned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID-19 vaccine in Bahrain, after launching similar ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
First Singapore volunteers given locally co-developed Covid-19 vaccine in trialSINGAPORE - The first cohort of local volunteers has been dosed with a coronavirus vaccine jointly developed by Duke-NUS Medical School and United States pharmaceutical company Arcturus Therapeutics.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »